Dong-Il Kim
Vermögen: 5 690 $ am 31.08.2026
Vermögen: 5 690 $ am 31.08.2026
Dong-Il Kim is currently an Independent Director at SunBio, Inc. since 2025 and a Professor at Inha University since 2012.
Former positions include Independent Director roles at SunBio, Inc. and Celltrion, Inc. Education includes a doctorate from Rutgers State University of New Jersey conferred in 1989, and undergraduate and graduate degrees from Seoul National University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SUNBIO, INC. 0.01% | 30.09.2025 | 1’250 ( 0.01% ) | 5 690 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SUNBIO,INC. | Direktor/Vorstandsmitglied | 31.03.2025 |
Inha University
Inha University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.06.2011 |
| Unternehmen | Position | Ende |
|---|---|---|
| SUNBIO,INC. | Direktor/Vorstandsmitglied | - |
| CELLTRION, INC. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SunBio, Inc.
SunBio, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies biopharmaceuticals, bio-similars and medical devices | Health Technology |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inha University
Inha University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celltrion, Inc.
Celltrion, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen